Laboratory News and Research

RSS

BD, PEPFAR commence multi-year initiative to improve blood collection practices in African clinics, hospitals

BD (Becton, Dickinson and Company), a leading global medical technology company, and the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Department of Health and Human Services' Centers for Disease Control and Prevention (CDC) today set in motion a joint, multi-year initiative to improve blood collection practices in African clinics and hospitals.

From BD (Becton, Dickinson and Company) 22 Jun 2010

Omega-3 effective for treating depression in patients without anxiety disorders

The use of Omega-3 supplements is effective among patients with major depression who do not have anxiety disorders, according to a study directed by Dr. Fran-ois Lesp-rance of the Centre de recherche du Centre hospitalier at the Universit- de Montr-al (CRCHUM), head of CHUM's Department of Psychiatry and a professor at the Universit- de Montr-al. The study was published June 15 in the online Journal of Clinical Psychiatry.

22 Jun 2010

Pfizer announces voluntary withdrawal of Mylotarg from U.S. market following FDA request

Pfizer Inc. today announced the voluntary withdrawal from the U.S. market of the drug Mylotarg (gemtuzumab ozogamicin) for patients with acute myeloid leukemia (AML), a bone marrow cancer. The company took the action at the request of the U.S. Food and Drug Administration after results from a recent clinical trial raised new concerns about the product's safety and the drug failed to demonstrate clinical benefit to patients enrolled in trials.

22 Jun 2010

Discoveries in study and manipulation of human ES cells win first prize in research competition

World-recognized discoveries in the study and manipulation of human embryonic stem cells have won first prize in a prestigious applied research competition for a Hebrew University of Jerusalem researcher.

22 Jun 2010

Celator announces expansion of research agreement with Cephalon

Celator Pharmaceuticals today announced that it has expanded its research agreement with Cephalon, Inc.. The research agreement provides for the utilization of Celator's proprietary technology in an ongoing drug development and life-cycle management program at Cephalon.

22 Jun 2010

CareGroup Healthcare System to implement InterSystems Ensemble rapid integration, development platform

InterSystems Corporation, the global leader in software for connected healthcare, today announced that CareGroup Healthcare System, a Boston-based integrated delivery network (IDN) comprised of four hospitals, has selected the InterSystems Ensemble® rapid integration and development platform to replace its legacy eGate platform for strategic integration throughout the organization.

21 Jun 2010

NanoViricides' anti-Dengue drug candidates demonstrate potential against severe virus infection

NanoViricides, Inc. reports that its anti-Dengue drug candidates demonstrated significant protection in the initial animal survival studies of Dengue virus infection. The studies were performed in the laboratory of Dr. Eva Harris, Professor of Infectious Diseases at the University of California, Berkeley.

21 Jun 2010

Severity of appendicitis can be predicted from blood sample, shows thesis

The symptoms of appendicitis are often diffuse and it can be difficult to obtain an accurate diagnosis early in the course of the disease. It may be possible to predict the severity from a blood sample, and in this way determine the treatment on an individual basis. This is the conclusion of a thesis presented at the University of Gothenburg, sweden.

21 Jun 2010

Canadian scientists describe safe, inexpensive way for kids to make microfluidic devices

With "hands-on" experiences in childhood and adolescence having sparked so many science careers, scientists in Canada are describing a quick, simple, safe, and inexpensive way for kids to participate in making microfluidic devices. Those devices are at the heart of lab-on-a chip, inkjet printing, DNA chip, and other technologies.

19 Jun 2010

Biomechanical implications of low-height falls in toddlers

An in-depth scientific article published in the July 2010 issue of Journal of Neurosurgery: Pediatrics, entitled Biomechanics of the toddler fall during low-height falls elucidates the impact of head injuries caused by low-height falls in toddlers, using an anthropomorphic biomechanical surrogate.

19 Jun 2010

PSC receives accreditation under UL's Data Acceptance Program to serve lighting and medical device industries

Following the successful completion of a rigorous audit by Underwriters Laboratories (Northbrook, IL) this month, Product Safety Consulting, Inc. (Bensenville, IL) announced today that they have received formal accreditation under UL's Data Acceptance Program to better serve two vibrant and growing sectors of the American economy: lighting products and medical devices.

19 Jun 2010

CPRIT awarded $142M in grants to fund cancer research and prevention programs across the state

The Cancer Prevention and Research Institute of Texas today awarded $142 million in grants to fund innovative cancer research and prevention programs across the state. Today's announcement caps the first year of the Institute's ten year mission. Together with matching funds committed by grant recipients, more than $300 million has been invested this year in Texas' extraordinary endeavor to change the face of cancer.

19 Jun 2010

Akela Pharma first-quarter net loss reduces to $0.4 million

Akela Pharma, Inc., a leader in the development of therapeutics for the treatment of pain, and the company's wholly owned subsidiary, PharmaForm, today announced its financial results for the three months ended March 31, 2010.

19 Jun 2010

Advisory panel recommends FDA approve new "morning after" pill

The New York Times: A Food and Drug Administration advisory panel Thursday recommended that the agency approve "a medicine that could help prevent pregnancy if taken as late as five days after unprotected sex. The pill, called ella, sprang from government labs and appears to be more effective than Plan B, a morning-after pill now available over the counter to women 18 and older that gradually loses efficacy after intercourse and can be taken at latest three days after sex.

18 Jun 2010

Interim epidemiological information on SLE patients in China presented at EULAR 2010

The Chinese Systemic Lupus Erythematosus Treatment and Research Group (CSTAR) announced interim epidemiological information on SLE patients in China today at EULAR 2010, the Annual Congress of the European League Against Rheumatism in Rome, Italy. Robust data on SLE patients has been scarce to date; but now CSTAR provides the first online registry of this magnitude in China. To date the registry has collated data from 2,104 SLE patients across 30 Chinese provinces.

18 Jun 2010

NeoStem announces presentation on very small embryonic-like stem cells at ISSCR 2010

NeoStem, Inc., an international biopharmaceutical company with operations in the U.S. and China, announced today that a poster authored by NeoStem-affiliated scientists will be presented in a presentation at the premier stem cell research event, the International Society for Stem Cell Research (ISSCR) 8th Annual Meeting in San Francisco on June 17, 2010.

18 Jun 2010

Special public meeting to spotlight stem cell-based therapies for ALS

Local scientists, health advocates and leaders from the California Institute for Regenerative Medicine will gather in San Diego June 23 for a special public meeting to spotlight a new University of California, San Diego grant to pursue novel, fast-tracked stem cell-based therapies for amyotrophic lateral sclerosis, or Lou Gehrig's disease.

18 Jun 2010

New multimillion dollar BSL-3 laboratory complex at Nigerian National TB and Leprosy Training Center

This week, the U.S. Centers for Disease Control (CDC) Director, Dr. Tom Frieden, visited the Nigerian National TB and Leprosy Training Center (NTBLTC) to tour a multimillion dollar laboratory complex established by the Institute of Human Virology (IHV) of the University of Maryland School of Medicine in Baltimore, Maryland, and the Institute of Human Virology-Nigeria. This U.S.-Nigeria partnership was established in 2004 through funding from the CDC and the President's Emergency Plan For AIDS Relief (PEPFAR).

18 Jun 2010

Blueberry consumption is beneficial for hepatic diseases: Study

Conventional drugs used in the treatment of liver diseases inevitably have side effects. An increasing number of natural substances have been studied to explore if they have protective effects on the liver. Blueberries have unique effects on human retinal, brain and tumor cells, but reports about the effects of blueberries on liver diseases are lacking.

18 Jun 2010

Laboratory mouse study shows cold sensing neural circuits develop well after birth

Cold sensing neural circuits in newborn mice take around two weeks to become fully active, according to a new study. The finding adds to understanding of the cold sensing protein TRPM8 (pronounced trip-em-ate), first identified in a Nature paper in 2002 by David McKemy of the University of Southern California.

18 Jun 2010

Laboratory News and Research

BD, PEPFAR commence multi-year initiative to improve blood collection practices in African clinics, hospitals

Omega-3 effective for treating depression in patients without anxiety disorders

Pfizer announces voluntary withdrawal of Mylotarg from U.S. market following FDA request

Discoveries in study and manipulation of human ES cells win first prize in research competition

Celator announces expansion of research agreement with Cephalon

CareGroup Healthcare System to implement InterSystems Ensemble rapid integration, development platform

NanoViricides' anti-Dengue drug candidates demonstrate potential against severe virus infection

Severity of appendicitis can be predicted from blood sample, shows thesis

Canadian scientists describe safe, inexpensive way for kids to make microfluidic devices

Biomechanical implications of low-height falls in toddlers

PSC receives accreditation under UL's Data Acceptance Program to serve lighting and medical device industries

CPRIT awarded $142M in grants to fund cancer research and prevention programs across the state

Akela Pharma first-quarter net loss reduces to $0.4 million

Advisory panel recommends FDA approve new "morning after" pill

Interim epidemiological information on SLE patients in China presented at EULAR 2010

NeoStem announces presentation on very small embryonic-like stem cells at ISSCR 2010

Special public meeting to spotlight stem cell-based therapies for ALS

New multimillion dollar BSL-3 laboratory complex at Nigerian National TB and Leprosy Training Center

Blueberry consumption is beneficial for hepatic diseases: Study

Laboratory mouse study shows cold sensing neural circuits develop well after birth

A guide to density measurement excellence eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo